Applies to Medicaid plans.
Covered with requirementsQualification pathways
You can qualify through any one of these.
MASH with moderate to advanced liver fibrosis
All of:
- Diagnosis of NASH or MASH
- Moderate to advanced liver fibrosis (F2 to F3)
Documentation to bring
- Diagnosis of NASH or MASH
- Documentation of fibrosis stage F2 or F3
Policy note: MASH indication for Wegovy was added January 5, 2026. The document describes coverage for 'moderate to advanced liver fibrosis' (F2 to F3). No additional details on confirmation methods, lookback periods, specialist requirements, alcohol limits, or approval duration were specified in this guideline update summary. Full criteria detail may exist in a separate policy document.
source: Fallon Health Plan Medicaid prior authorization policy · View policy document (PDF)